Introduction
Parkinson's disease (PD) is the most common movement disorder and is pathologically characterized by selective dopaminergic neuronal death. Abundant evidence points to a causative role for the presynaptic protein a-synuclein (a-syn) in the pathogenesis of PD (Spillantini et al., 1998; Mizuno et al., 2008) . a-Syn is a major component of Lewy Bodies, cellular inclusion bodies that are the hallmark pathological feature of PD (Spillantini et al., 1998) . The duplication and triplication of the a-syn gene appears to be the cause of PD in rare cases of familial forms of PD (Singleton et al., 2003; Chartier-Harlin et al., 2004; Ibá ñez et al., 2004 ). An overexpression of a-syn leads to neurodegeneration in mouse, rat, fly, and nematode models of PD (Cooper et al., 2006; Auluck et al., 2002; Lo Bianco et al., 2002; Masliah et al., 2000; Cao et al., 2005) .
These data show that storage of a-syn may be involved in the pathogenesis of PD. Recent studies have shown that an overexpression of a-syn can induce a mitochondrial deficit (Hsu et al., 2000) , enhanced vulnerability to oxidative stress (Hsu et al., 2000; Prasad et al., 2004) and inhibition of endoplasmic reticulum (ER)-Golgi trafficking (Cooper et al., 2006; Sugeno et al., 2008) . Moreover, other reports suggest that catecholamine (CA) such as dopamine (DA) and DOPA can stabilize the protofibrillar form of a-syn (Conway et al., 2001 ) and endogenous DA enhances cell death associated with soluble a-syn protein (Xu et al., 2002) . However, the association of endogenous CA with a-syn toxicity is still unclear.
Numerous studies of PD rely on drug models using 1-methyl-4-phenyl-pyrisinium (MPP+), rotenone and 6-hydroxydopamine (6-OHDA). These agents cause a DA-neuronal death and PD-like phenotype in animal models. These agents also induce the unfolded protein response (UPR) in ER (Holtz and O'Malley, 2003; Ryu et al., 2002) . Dysfunction of Parkin, a gene product responsible for autosomal recessive juvenile Parkinsonism (AR-JP), is linked to ER stress and the UPR (Imai et al., 2002 (Imai et al., , 2001 . Accumulating genetic and molecular evidence suggests that defects in the ER contribute to the pathogenesis of PD. Thapsigargin increased the SDS soluble oligomers of a-synuclein associated with catecholaminequinone. The unfolded protein response (UPR) study showed that thapsigargin increased eIF2a phosphorylation and nuclear GADD153/CHOP induction under a-synuclein overexpressed conditions. The activities of the ATF6a and IRE1a pathways decreased. These findings suggest that an overexpression of a-synuclein partly inactivates the UPR. a-Methyltyrosine inhibited the dysfunction of the UPR caused by an overexpression of human a-synuclein. Therefore, these findings suggest that the coexistence of human a-synuclein with catecholamine enhances the endoplasmic reticulum stressrelated toxicity in PD pathogenesis.
ß 2009 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
Abbreviations: DMEM, Dulbecco's Modified Eagle Medium; SDS, sodium dodecyl sulfate.
